Submission Details
| 510(k) Number | K222237 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 26, 2022 |
| Decision Date | November 22, 2022 |
| Days to Decision | 119 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K222237 is an FDA 510(k) clearance for the Cala kIQ, a External Upper Limb Tremor Stimulator (Class II — Special Controls, product code QBC), submitted by Cala Health, Inc. (San Mateo, US). The FDA issued a Cleared decision on November 22, 2022, 119 days after receiving the submission on July 26, 2022. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5897.
| 510(k) Number | K222237 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 26, 2022 |
| Decision Date | November 22, 2022 |
| Days to Decision | 119 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | QBC — External Upper Limb Tremor Stimulator |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.5897 |
| Definition | An External Upper Limb Tremor Stimulator Is A Prescription Device Which Is Placed Externally On The Upper Limb And Designed To Aid In Tremor Symptom Relief Of The Upper Limb. |